Skip to main content
Top
Published in: BMC Infectious Diseases 1/2009

Open Access 01-12-2009 | Research article

Evaluation of surveillance case definition in the diagnosis of leptospirosis, using the Microscopic Agglutination Test: a validation study

Authors: Dinesh LB Dassanayake, Harith Wimalaratna, Suneth B Agampodi, Veranja C Liyanapathirana, Thibbotumunuwe ACL Piyarathna, Bimba L Goonapienuwala

Published in: BMC Infectious Diseases | Issue 1/2009

Login to get access

Abstract

Background

Leptospirosis is endemic in both urban and rural areas of Sri Lanka and there had been many out breaks in the recent past. This study was aimed at validating the leptospirosis surveillance case definition, using the Microscopic Agglutination Test (MAT).

Methods

The study population consisted of patients with undiagnosed acute febrile illness who were admitted to the medical wards of the Teaching Hospital Kandy, from 1st July 2007 to 31st July 2008. The subjects were screened to diagnose leptospirosis according to the leptospirosis case definition. MAT was performed on blood samples taken from each patient on the 7th day of fever. Leptospirosis case definition was evaluated in regard to sensitivity, specificity and predictive values, using a MAT titre ≥ 1:800 for confirming leptospirosis.

Results

A total of 123 patients were initially recruited of which 73 had clinical features compatible with the surveillance case definition. Out of the 73 only 57 had a positive MAT result (true positives) leaving 16 as false positives. Out of the 50 who didn't have clinical features compatible with the case definition 45 had a negative MAT as well (true negatives), therefore 5 were false negatives. Total number of MAT positives was 62 out of 123. According to these results the test sensitivity was 91.94%, specificity 73.77%, positive predictive value and negative predictive values were 78.08% and 90% respectively. Diagnostic accuracy of the test was 82.93%.

Conclusion

This study confirms that the surveillance case definition has a very high sensitivity and negative predictive value with an average specificity in diagnosing leptospirosis, based on a MAT titre of ≥ 1: 800.
Appendix
Available only for authorised users
Literature
1.
go back to reference Epidemiological Unit: Selected notifiable diseases reported by Medical Officers of Health. Weekly Epidemiological Report. 2007, 34: 4- Epidemiological Unit: Selected notifiable diseases reported by Medical Officers of Health. Weekly Epidemiological Report. 2007, 34: 4-
2.
go back to reference Bajani MD, Ashford DA, Bragg SL, Woods CW, Aye T, Spiegel RA, Plikaytis BD, Perkins BA, Phelan M, Levett PN, Weyant RS: Evaluation of four commercially available rapid serologic tests for diagnosis of leptospirosis. J Clin Microbiol. 2003, 41: 803-809. 10.1128/JCM.41.2.803-809.2003.CrossRefPubMedPubMedCentral Bajani MD, Ashford DA, Bragg SL, Woods CW, Aye T, Spiegel RA, Plikaytis BD, Perkins BA, Phelan M, Levett PN, Weyant RS: Evaluation of four commercially available rapid serologic tests for diagnosis of leptospirosis. J Clin Microbiol. 2003, 41: 803-809. 10.1128/JCM.41.2.803-809.2003.CrossRefPubMedPubMedCentral
3.
go back to reference Ahmad SN, Shah S, Ahmad FM: Laboratory diagnosis of leptospirosis. J Postgrad Med. 2005, 51: 195-200.PubMed Ahmad SN, Shah S, Ahmad FM: Laboratory diagnosis of leptospirosis. J Postgrad Med. 2005, 51: 195-200.PubMed
4.
go back to reference Kobayashi Y: Human leptospirosis: management and prognosis. J Postgrad Med. 2005, 51: 201-204.PubMed Kobayashi Y: Human leptospirosis: management and prognosis. J Postgrad Med. 2005, 51: 201-204.PubMed
5.
go back to reference Brato DG, Mendoza MT, Cordero CP: Validation of the World Health Organization (WHO) Criteria Using the Microscopic Agglutination Test (MAT) as the Gold Standard in the Diagnosis of Leptospirosis. Phil J Microbiol Infect Dis. 1988, 27: 125-128. Brato DG, Mendoza MT, Cordero CP: Validation of the World Health Organization (WHO) Criteria Using the Microscopic Agglutination Test (MAT) as the Gold Standard in the Diagnosis of Leptospirosis. Phil J Microbiol Infect Dis. 1988, 27: 125-128.
6.
go back to reference Epidemiology Unit: Leptospirosis. Surveillance Case Definitions for Notifiable Diseases in Sri Lanka. 2005, Colombo: Epidemiology Unit, Ministry of Health, 19-20. Epidemiology Unit: Leptospirosis. Surveillance Case Definitions for Notifiable Diseases in Sri Lanka. 2005, Colombo: Epidemiology Unit, Ministry of Health, 19-20.
8.
go back to reference Somarathna P: Leptospirosis-re-emerging in a changing pattern?. The Bulletin of the Sri Lanka College of Microbiologists. 2008, 6: 59-62. Somarathna P: Leptospirosis-re-emerging in a changing pattern?. The Bulletin of the Sri Lanka College of Microbiologists. 2008, 6: 59-62.
10.
go back to reference World Health Organization: Human leptospirosis – guidance for diagnosis, surveillance and control. 2003, Malta: World Health Organization, 1-122. World Health Organization: Human leptospirosis – guidance for diagnosis, surveillance and control. 2003, Malta: World Health Organization, 1-122.
Metadata
Title
Evaluation of surveillance case definition in the diagnosis of leptospirosis, using the Microscopic Agglutination Test: a validation study
Authors
Dinesh LB Dassanayake
Harith Wimalaratna
Suneth B Agampodi
Veranja C Liyanapathirana
Thibbotumunuwe ACL Piyarathna
Bimba L Goonapienuwala
Publication date
01-12-2009
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2009
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-9-48

Other articles of this Issue 1/2009

BMC Infectious Diseases 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.